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two or more pathogens. It is possible that all three mech-
anisms are at work, at least to some degree. The propor-
tion of CD8 T cells expressing memory markers suchSummary
as CD44 does increase with age, but homeostatic regu-
lation controlling the size of the spleen and lymph nodesUsing a variety of techniques, including limiting di-
places an upper limit on the total number of memorylution assays (LDA), intracellular IFNg assays, and
cells, precluding numbers which could accommodateDb-IgG1 MHC dimer staining to measure viral peptide-
many infections producing memory T cells at the levelsspecific T cell number and function, we show here that
produced by LCMV. Thus, there must be a deletion of
heterologous virus infections quantitatively delete and
preexisting memory populations when the host re-
qualitatively alter the memory pool of T cells specific
sponds to another pathogen.
to a previously encountered virus. We also show that
Marked decreases in pCTL occur in mice sequentially
a prior history of a virus infection can alter the hierar-
infected with a series of viruses that elicit systemic infec-
chy of the immunodominant peptide response to a tions and strong CD8 T cell responses (Selin et al., 1996).
second virus and that virus infections selectively reac- Mice infected with LCMV and then, at 2 or more month
tivate memory T cells with distinct specificities to ear- intervals, with Pichinde virus (PV), vaccinia virus (VV),
lier viruses. These results are consistent with a model and murine cytomegalovirus (MCMV) reduced pCTL fre-
for the immune system that accommodates memory quencies specific to all previous viruses with each suc-
T cell populations for multiple pathogens over the cessive viral infection. On average, one systemic virus
course of a lifetime. infection reduced pCTL specific to an earlier virus by
3-fold, and two additional infections reduced pCTL to
an earlier virus by 8-fold. The degree of pCTL reductionIntroduction
was not, however, proportionally equal between differ-
ent viruses, as, for example, an infection that reducedAntigen-specific CD8 T cells generated during acute
LCMV-specific pCTL by 2-fold in the same mice reducedviral infections enter the memory pool and provide host
PV-specific pCTL by 5-fold. This suggests that qualita-resistance on reexposure to the virus. The development
tive changes relating to the T cell specificity may beof antigen-specific T cell staining using tetrameric (Alt-
influencing the degree of memory T cell attrition. Theseman et al., 1996) or dimeric (Greten et al., 1998) peptide/
data in support of the loss of memory CD8 T cells byMHC complexes as well as intracellular cytokine staining
heterologous virus infections were generated by LDA,has made it possible to visualize antigen-specific T cells.
which depended on outgrowth of T cells and their cyto-Studies indicate that a high portion of CD8 T cells can
lytic function. They did not distinguish between deletedbe virus specific during the acute and memory phase
T cell populations versus present but functionally inac-of the immune response (Butz and Bevan, 1998; Callan
tive T cell populations, now known to exist at high levelset al., 1998; Flynn et al., 1998; Murali-Krishna et al.,
in persistent virus infections (Oxenius et al., 1998; Zajac1998); 40%±60% of the CD8 T cells in LCMV-infected
et al., 1998).mice can be shown to be virus specific during the acute
An important factor that might influence the declinephase of the response, and over 10% of the CD8 T cells
in CTL memory after heterologous viral infections isremain virus specific after the immune system returns to
whether or not putatively unrelated pathogens canhomeostasis (Murali-Krishna et al., 1998). Virus-specific
cross-reactively stimulate memory T cells specific toCTL memory is extremely stable, as demonstrated origi-
previously encountered viruses. Although the T cell re-nally by LDA, which showed that CTL precursor (pCTL)
sponse to an infection is predominantly specific for thefrequencies for several viruses and for each of three
virus, it is also degenerate in that many of the virus-LCMV-encoded immunodominant epitopes (NP396,
specific T cells can recognize other antigens. It has been
GP33, and GP276) can remain stable for up to 2 years
calculated that a single TCR may recognize up to a
(Oehen et al., 1992; Hou et al., 1994; Lau et al., 1994;
million different peptide sequences (Mason, 1998). Our
studies have shown that viruses once thought not to be
cross-reactive at the levels of T cells can elicit cross-§ To whom correspondence should be addressed (e-mail: raymond.
welsh@umassmed.edu). reactive responses if an immune system biased by a
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Figure 1. Selective Deletion of LCMV Epitope±Specific Memory pCTL by Subsequent Heterologous Virus Infections Resulting in Alterations
in the Proportion of LCMV Peptide±Specific CD8 pCTL
C57BL/6 mice were infected with heterologous viruses sequentially, and splenocytes were harvested from mice in the resting immune state
and set up in LDAs to determine the LCMV epitope±specific pCTL/f as described in Experimental Procedures. In (A) the data are listed as
percent of CD8 to make it easier to compare to the intracellular IFNg and Db-IgG1 MHC dimer staining data. (B) is a LCMV epitope±specific
proportional summary of the data from these same mice. The number of mice per group is recorded in (B). The numbers displayed in (A)
represent the fold decrease of each epitope-specific population as compared to the LCMV-immune mice alone. ªNOº means that there was
no decrease in that epitope-specific population.
memory T cell pool specific for one virus is challenged these proportions and hierarchy as a consequence of
heterologous infections can be shown to be highly sta-with a heterologous virus. A low frequency of memory
T cells in the starting population that can be stimulated tistically significant.
Figure 1A demonstrates by LDA that heterologouscross-reactively with the second virus quickly expands
and may enhance viral clearance of the second infection viral infections cause an overall reduction of the LCMV-
specific pCTL frequency, as shown here by summingor contribute to immunopathogenesis (Selin and Welsh,
1994; Selin et al., 1994, 1998; Welsh et al., 1997). This the frequencies of the three immunodominant peptides.
As shown previously (Selin et al., 1996), homeostasistype of cross-reactive expansion might enable unrelated
viruses to qualitatively as well as quantitatively change in lymphoid number occurred by 6 weeks after each
infection. The numbers of splenic leukocytes after 2the memory T cell pools specific for previously encoun-
tered infectious agents. We show here that heterologous (1.1 3 108 6 .1 SEM, n 5 12), 3 (1.1 3 108 6 .1; n 5 7), 4
(1.0 3 108 6 .1; n 5 8), or 5 (0.9 3 108 6 .1; n 5 4)viruses quantitatively delete and qualitatively alter the
memory pool of T cells specific to a previously encoun- infections were no greater than after the initial LCMV
infection (0.9 3 108 6 .1; n 5 14). Similarly, the percenttered virus.
of CD8 spleen cells did not significantly change over
time: LCMV (14% 6 1.4%); LCMV1PV (13% 6 2.1%);Results
LCMV1PV1VV (14.8% 6 2.3%); LCMV1PV1VV1
MCMV (12% 6 1.1%); LCMV1PV1VV1MCMV1VSVSelective Deletion of LCMV Epitope±Specific
(14.6% 6 1.7%). Since there were no significant changesMemory pCTL by Subsequent Heterologous
in the total CD8 number per mouse, the data are pre-Virus Infections
sented as the percent of antigen-specific CD8 T cells.Having previously demonstrated that pCTL frequencies
The combined frequencies derived from targetsanalyzed on LCMV-infected targets decrease with each
pulsed with the three peptides are about double that ofof several successive heterologous infections (Selin et
the frequencies we have reported with virus-infectedal., 1996), we questioned whether there were equal re-
targets, which may be less efficient at detecting low-ductions in the frequencies to each of three LCMV-
affinity responses. One subsequent virus infection withencoded immunodominant peptides. The purpose of
either MCMV or PV resulted in an approximately 1.5-foldthis experiment was to determine if there were qualita-
(about 33%) reduction in the combined LCMV peptide-tive changes in the memory CTL response to LCMV as
specific pCTL, from 5.2% of the CD8 splenic T cells toa consequence of other viral infections. Figure 1B shows
3.5%. Two subsequent viral infections (PV1VV) resultedby LDA the proportion of the LCMV-specific memory T
in a 1.7-fold (44%) decrease in LCMV-specific pCTLcell response accounted for by the 3 peptides in 14 mice
to 2.9% of the CD8. Three subsequent virus infectionsanalyzed over a period of 2 years. Note that the hierarchy
(PV1VV1MCMV) resulted in a 3.5-fold (71%) reductionis GP33.NP396.GP276 and that the standard devia-
tions for these values are small. Thus, divergences in to 1.5% of the CD8 (p , .001), while four virus infections
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Figure 2. Prior Infection with a Heterologous Virus before Exposure to LCMV Alters LCMV Epitope±Specific Responses and Their Subsequent
Deletion Resulting in Alterations in the Proportion of LCMV Peptide±Specific CD8 pCTL
(B) is an LCMV epitope±specific proportional summary of the data from these same mice. The number of mice per group is recorded in (B).
The numbers displayed in (A) represent the fold decrease of each epitope-specific population as compared to the LCMV-immune mice alone.
(PV1VV1MCMV1VSV) resulted in a 5.4-fold (82%) de- has been previously exposed and that this mechanism
may involve a selective process, as not all epitope-spe-crease to 0.96% of the CD8 (p , .04). In contrast, chal-
lenge of LCMV-immune mice with LCMV caused a slight cific populations are reduced in equal proportions.
elevation in the LCMV-specific pCTL frequency, though
this increase was not statistically significant.
Figures 1A and 1B demonstrate that this total com- History of a Prior Infection with a Heterologous
Virus before Exposure to LCMV Alters thebined loss of LCMV epitope±specific memory pCTL after
heterologous viral infections is selective and dependent LCMV Epitope±Specific Responses and
Their Subsequent Deletion Patternon the virus sequence. Figure 1A shows that PV infection
after LCMV resulted in a predominantly GP33-specific A prior exposure to heterologous viruses before LCMV
infection also affects the LCMV-specific T cell pool (Fig-reduction that reversed if the mice were then infected
with VV. In the LCMV-immune mouse, 61.1% of the pCTL ures 2A and 2B). Prior immunity to PV resulted in 1.6-
fold lower total LCMV-specific pCTL (5.2% vs 3.3%), andwere GP33-specific, but after PV infection this de-
creased to 50.5%, and the NP396-specific frequency the epitope-specific pCTL repertoire was qualitatively
different. NP396 represented 49.2% of the repertoire asincreased from 30.4% to 40.5% of the memory pool.
Subsequent VV infection of LCMV1PV-immune mice compared to only 30.4% in the control LCMV-immune
repertoire. There was also a greater portion of pCTLdramatically altered the peptide-specific response.
There appeared to be a preservation of GP33-specific specific to GP276 (20.2%) in comparison to the control
LCMV-immune mice (8.5%). When the PV1LCMV-pCTL by VV but a loss in NP396-specific memory pCTL
(p , .03), as at this point the GP33-specific response immune mice were subsequently exposed to VV and
then to MCMV, there was a greater (2.7-fold) deletion ofrepresented 74.8% of the LCMV-specific memory pool.
When MCMV followed VV infection, there was a further the NP396-specific memory pool than the GP33-specific
pool, whose proportion rose from 30.5% to 45.5%.reduction in the total LCMV-specific pCTL, leaving the
host with 5.3-fold decrease in GP33-specific pCTL (p , Mice previously immune to VV before infection with
LCMV also had a 1.7-fold lower total LCMV-specific.005), but only a 1.4-fold decrease in GP276-specific
and a 2.7-fold decrease in NP396 responses compared pCTL pool. Their T cell repertoire to LCMV was also
altered in comparison to the LCMV-only pool, with ato the LCMV-immune control. At this point GP33 (43.8%)
and NP-396 (42.7%) specific pCTL represented about more equal proportion of GP33 (45.1%) and NP396
(37.7%) specific pCTL. The GP276-specific responseequal portions of the memory pool, and the proportion
of GP276-specific pCTL had increased to 13.5%. VSV was also increased proportionally and represented
17.3% versus 8.5% of the LCMV-only pool. Theinfection further decreased the GP33-specific pool so
that it was 7.7-fold less than the original memory pool VV1LCMV-immune mice, when subsequently exposed
to PV and then MCMV, demonstrated an equal propor-in LCMV-only immune mice (p , .04), and the proportion
of the response that was GP276-positive further in- tional loss against each of the three peptides in compari-
son to the VV1LCMV-immune mice. The total numbercreased to 15.3%. Rechallenge of LCMV-immune mice
with LCMV resulted in proportional increases in the of LCMV-specific pCTL was quite reduced in the
VV1LCMV1PV1MCMV-immune mice. These experi-NP396-specific pCTL. Collectively, these results sug-
gest that there is a mechanism that results in the attrition ments indicate that when the memory T cell pool con-
tains T cells specific to a previously encountered virus,of memory T cells specific to viruses to which the host
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the nature of the T cell response to a subsequent viral
infection is altered.
Selective Reduction of Epitope-Specific Memory
CD8 T Cells as Assayed by Intracellular
IFNg Staining
Because LDAs require first the outgrowth of T cells in
culture and then a functional cytotoxicity assay, we
deemed it important to analyze T cell attrition by addi-
tional mechanisms. We therefore used the technique of
intracellular IFNg staining.
Figure 3i shows in age-matched mice that subsequent
heterologous viral infections elicited an overall decrease
in the percentage of LCMV-specific IFNg-producing
CD8 memory T cells. Totaling the peptides NP396±404,
GP33±43, and GP276±286, PV infection of LCMV-immune
mice resulted in an approximately 1.6-fold decrease
(total %57.3) in LCMV-specific IFNg-producing CD8
T cells; two subsequent viruses (PV1VV) resulted in a
1.8-fold (total percent 5 6.3) decrease in LCMV-specific
IFNg-producing CD8 T cells; three subsequent viruses
(PV1VV1MCMV) resulted in a 3.9-fold decrease (total
percent 5 3.7) in LCMV-specific IFNg-producing CD8
T cells.
We have up to this time used the GP33±43 peptide in
our LDA CTL analyses based on the assumption that in
the 18 hr incubation on target cells, it will be processed
by cellular proteases and will be presented both as an
H-2Db (GP33±41) as well as an H-2Kb (GP33±43) epitope.
However, in the much shorter intracellular IFNg assay,
it may not be processed as efficiently. Also, the Db-IgG1
MHC dimer, which will be described in the next section,
Figure 3. Selective Reduction of LCMV-Specific Memory CD8 Twill only load with the GP33±41 peptide. Therefore, in
Cells as Assessed by Intracellular IFNg Stainingthe IFNg assay presented in Figure 3, the T cells were
(i) Selective reduction of LCMV epitope±specific memory CD8 Talso stimulated with GP33±41. The GP33±41 peptide
cells by subsequent heterologous virus infections as assessed bygave very similar results to GP33±43, except that it de-
intracellular IFNg staining. Each panel represents a pool of spleno-fined a higher frequency of the LCMV-specific memory
cytes from three similarly infected mice. These are representative
CD8 T cells (Figure 3i). Using the GP33±41 epitope to data from one of three similar experiments. The x axis represents
detect frequencies, 14.6% of the CD8 cells were scored CD8 FITC staining and the y axis represents IFNg PE staining. The
numbers recorded in the right upper quadrants represent the per-as virus specific; this was reduced to 3.6% after three
cent of IFNg-staining CD8 cells specific for that epitope. The numberadditional virus infections.
below this represents the fold decrease of each epitope-specificThe intracellular IFNg assay results also demonstrated
population from the LCMV-only immune mice. The two differenta selective reduction in LCMV epitope±specific CD8
forms of GP33, GP33±43 and GP33±41, were used in these experi-
memory T cells similar to that observed in LDAs. For ments. The percentage to the left of each group is the total LCMV-
example, after three subsequent viruses there was a 5.5-, specific CD8 frequency (NP396±404, GP33±43, and GP276±286) and
below that is the fold decrease from the LCMV-only immune mice.3.9-, and 2.4-fold decrease in GP33±43-, NP396±404-,
The percentage to the left of each group presented in bracketsand GP276±286-specific CD8 memory T cells, respec-
is the total LCMV-specific CD8 frequency summing NP396±404,tively. There was also a very reproducible selective loss
GP33±41, and GP276±296 responses and below that is the foldof memory T cells producing the highest amount of IFNg,
decrease from the LCMV-only immune mice.
as those cells staining most brightly were greatly re- (ii) Comparison of selective deletion of LCMV epitope±specific mem-
duced in frequency after subsequent infections (Figure ory CD8 T cells by heterologous virus infections by LDA and intracel-
lular IFNg staining. The pCTL/f in LCMV-immune mice and in3). The NP396-specific IFNg staining mean fluorescence
LCMV1PV1VV1MCMV-immune mice is the mean of 14 and 7 differ-intensity decreased 81% from 1241 to 237 after three
ent mice, respectively. The LCMV-immune and LCMV1PV1VV1subsequent infections, while GP33±41 dropped 46%
MCMV-immune mice IFNg results represent the mean of two experi-from 695 to 377 and GP276 dropped 23% from 489 to
ments in which three mice were pooled. The VV1LCMV-immune
377. This might indicate that higher affinity cells specific and the VV1LCMV1PV1MCMV-immune mice data for both tech-
for LCMV are preferentially lost on subsequent heterolo- niques are based on the means of the same six mice. The numbers
displayed in the figure represent the fold decrease of each epitope-gous viral infections.
specific population as compared to the LCMV-immune orFigure 3ii provides additional studies showing that the
VV1LCMV-immune mice.LDA and IFNg techniques give similar results in paired
assays, although the IFNg assay was about 2-fold more
efficient. The IFNg assay demonstrated proportionally
higher GP276 responses than the LDA technique, but
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both assays showed a very similar proportional de-
crease in each epitope-specific response in LCMV-
immune mice challenged with three subsequent viruses.
The greatest proportional decrease in both assays was
that of the GP33 response (5.3- or 5.5-fold). The observa-
tion that the GP276-specific CD8 population may repre-
sent a greater proportion of the IFNg-producing cell
response may indicate functional differences in the
LCMV epitope±specific memory populations or the pos-
sibility that GP276-specific pCTL do not grow out well
in LDAs.
Selective Reduction of Epitope-Specific Memory Cells
as Assessed by Db-IgG1 MHC Dimer Staining
To directly enumerate antigen-specific memory T cells,
we generated Db-IgG1, a soluble divalent Db complex,
and used it to visualize antigen-specific CD8 T cells. To
confirm the specificity of the reagent, Db-IgG1 com-
plexes were loaded with peptides of interest and used
to stain spleen cells from mice infected with LCMV or
PV (Figure 4i). In a pool of splenocytes from two day 8
LCMV-infected mice, a total of 27.4% of the CD8 cells
scored as LCMV specific. In contrast, very little staining
was seen on T cell populations from control mice (data
not shown) or from PV-infected mice (Figure 4i), which
have a vigorous expansion of activated T cells, much
like that of LCMV.
The levels of LCMV-specific memory CD8 cells detect-
able by the Db-IgG1 MHC dimer (8.8%) were comparable
to though slightly lower than that detected by intracellu-
lar IFNg staining (Figure 4ii), mainly due to the lower
efficiency of the GP33±41 dimer. After subsequent infec-
tions (PV1VV1MCMV) there was a 1.8-fold decrease (to Figure 4. Selective Reduction of LCMV-Specific Memory CD8 T
Cells as Assessed by Db-IgG1 MHC Dimer Staining4.9%), and after four viruses there is a 2.7-fold decrease
(i)Db-IgG1 MHC dimer staining of LCMV day 8 infected and PV day(to 3.3%) in LCMV-specific CD8 T cells. There was also
7 infected splenocytes. The x axis represents CD8 FITC staining,evidence of a selective loss of epitope-specific memory
and the y axis represents the peptide-Db-IgG1 MHC dimer staining.CD8 T cells, as after four subsequent virus infections
The y axis in the control FACS represents the secondary anti-IgG1there was a 4.3-fold loss in GP33-specific CD8 memory mAb without Db-IgG1 MHC dimer. The numbers recorded in the right
T cell loss but only a 2.9-fold loss of NP396-specific upper quadrant of each FACS plot represent the percentage of CD8
memory cells. The deletion of antigen-specific memory T cells specific for that epitope.
(ii) Selective reduction of LCMV epitope±specific memory CD8 TT cells seen using Db-IgG1 were a little less dramatic
cells by heterologous viruses as assessed by Db-IgG1 MHC dimerthan for LDA or the intracellular IFNg technique. This
staining. Each data point represents a pool of splenocytes fromcould imply that there are some functionally inactive T
three similarly infected mice. These data are representative of threecells still present in the memory population, but this similar experiments. The x axis represents CD8 FITC staining and
could be a technical issue of resolution of distinct popu- the y axis represents Db-IgG1 MHC dimer staining. The numbers
lations over background binding, which was usually recorded in the right upper quadrant of each FACS plot are the
percentage of CD8 T cells specific for that epitope. The numberabout 1%.
below this represents the fold change of each epitope-specific pop-
ulation from the LCMV-immune mice. The percentage to the left ofReactivation of LCMV Epitope±Specific Memory
each group is the total LCMV-specific CD8 frequency and below
T Cells by Acute Infection with VV or PV that is the fold decrease from the LCMV-immune mice.
LCMV-specific memory CTL can be reactivated from
LCMV-immune mice by acute infections with heterolo-
gous viruses such as VV or PV (Yang et al., 1989; Selin LCMV parent strain or to different LCMV mutant viruses
that had partial deletions of their responses to the NPet al., 1994). We have demonstrated cross-reactive T
cell clones specific between LCMV and PV and between epitope (NPV), GP33 epitope (GP1V), or all three immu-
nodominant epitopes (GPNPV) (Figure 5A). These vi-LCMV and VV, but the relative importance of cross-
reactivity versus nonspecific bystander activation in the ruses contain single amino acid alterations in the spe-
cific epitopes and were generated by Oldstone et al.reactivation of LCMV-specific memory cells has not
been clarified. The following experiments were designed (1995) by culturing the virus in the presence of a T cell
clone specific to the epitope that was to be deleted.to determine whether this reactivation in bulk is a non-
specific bystander activation or whether there is selec- Figure 5A shows bulk CTL assays of splenocytes from
acutely infected mice 8 days postinfection. The parenttivity in this reactivation, which would be suggestive of
a role for cross-reactivity. Mice were immunized to the strain generated a response with the normal hierarchy
Immunity
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Figure 6. Alterations in the LCMV Epitope±Specific Usage upon Re-
challenge with a Secondary LCMV Infection after Subsequent Heter-
ologous Virus Infections
(A) demonstrates the proportion of the LCMV peptide-specific CTLFigure 5. Heterologous Viral Challenge of Mice Immune to LCMV
and (B) demonstrates the LCMV epitope±specific lysis (LU/106). TheMutant Viruses
target cells were RMA-S cells incubated overnight with a 25 mM
(A) LCMV epitope±specific bulk CTL responses in mice acutely in- concentration of peptide.
fected (Day 8) with LCMV or the three LCMV mutant viruses: NPV
(deletion of NP epitope), GP1V (deletion of GP33 epitope), and
GPNPV (deletion of all three LCMV epitopes). Reactivation of differ-
homology to LCMV, both NP396 and GP33 epitope-ent LCMV epitope±specific memory T cells in LCMV mutant virus
immune mice by acute infection with PV (B) or VV (C). The target specific memory CTL were reactivated, suggesting that
cells used are peptide-coated RMA-S cells. Each data point is the both of these epitopes may be cross-reactive between
mean of three different experiments. LCMV- and PV-specific CD8 T cells; no such activity
was found in naive mice infected with PV (Selin and
Welsh, 1997). Nevertheless, there were proportional
of GP33.NP396.GP276, much like that observed with changes in epitope-specific responses that did not re-
LDA for pCTL in immune mice. The NP396 mutant (NPV) flect the hierarchy established by the original LCMV in-
generated a much reduced response to NP396, the fection. For instance, the NPV acutely infected mouse
GP33 mutant (GP1V) had a reduced response to GP33, had a 7-fold greater GP33-response compared to
and the mutant in all three epitopes (GPNPV) generated NP396, whereas the NPV-immune mice challenged with
a weak response to all three epitopes, much as would PV demonstrated a significant reactivation of the NP396-
be expected. There was in each case, however, still specific response, which was only 1.7-fold less than the
some level of recognition against the putatively deleted GP33-specific CTL response. It is also noteworthy that
epitopes, presumably by T cells that do not require the acute PV infection proportionally increased the NP396
particular amino acids that were deleted to interact with response in mice immune to wild-type LCMV, and this is
this peptide. These viruses nevertheless gave us the reflected in the data on pCTL frequencies in LCMV1PV-
opportunity to generate LCMV-specific memory T cell immune mice, which showed proportionally higher
populations containing different proportions of memory NP396 responses than LCMV-only immune mice (Fig-
T cells specific to the three immunodominant epitopes. ure 1B).
When the LCMV mutant immune mice were chal-
lenged with VV, there was a preferential reactivation of Alterations in the Acute LCMV Epitope±Specific
GP33-specific CTL, regardless of which LCMV variant Response upon Rechallenge with LCMV
was used to immunize the mice. VV does not induce an after Subsequent Heterologous
LCMV GP33-specific CTL response in naive mice not Virus Infections
immunized against LCMV (data not shown). These re- If subsequent heterologous virus infections were alter-
sults indicate that the VV-induced reactivation of LCMV- ing the LCMV-specific memory CTL repertoire, mice re-
specific CTL is a selective process more consistent with challenged with LCMV should have altered specificities
a cross-reactivity than a bystander reactivation mecha- of their secondary CTL response, as shown in Figures
nism. When LCMV mutant-immune mice were chal- 6A and 6B. Here either naive mice, LCMV-immune,
LCMV1PV-immune, LCMV1PV1VV-immune, LCMV1lenged with PV, an arenavirus with more (but still distant)
Selective Attrition of CD8 Memory T Cells
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Figure 7. Modulations in the LCMV-Specific
TcR Usage as Assessed by Vb8.1-Jb1.3
Spectratype Analysis upon Rechallenge with
LCMV after Subsequent Heterologous Virus
Infections
Experiment 1: peripheral blood (PB) samples
from four control mice were obtained at 9
days after primary LCMV infection (d9 LCMV),
6 weeks after injection of purified culture su-
pernatant (LCMV1pC. S.-imm), and 5 days
after secondary LCMV infection (LCMV1pC.
S.1d5 LCMV). PB from another four mice that
had received four virus infections were ob-
tained at 9 days after primary LCMV infection,
6 weeks after VV infection (LCMV1PV1VV-
imm), and 5 days after secondary LCMV in-
fection (LCMV1PV1VV1d5 LCMV).
Experiment 2: PB from three control mice and
four multiple virus-infected mice were ob-
tained as described in Experiment 1. Changes
in the spectratypes are marked with as-
terisks.
PV1VV1MCMV-immune, or mice infected with LCMV spectratype analyses, which have shown that some
clones are so dominant that their spectratypes can betwice previously were challenged with LCMV. At 6 days
postinfection, we quantified which LCMV immunodomi- observed for many months after infection (Lin and
Welsh, 1998). Other less dominant clones appearingnant peptide-coated targets were lysed in bulk CTL
assays. Figure 6B shows that the total magnitude of the during the acute infection become unresolvable by
spectratype analysis in the memory state, probably duesecondary CTL response decreased after several viral
infections, a result consistent with our LDA data showing to dilution with naive T cells, but they will then reemerge
on secondary challenge with LCMV. We hypothesized,reductions in the total CTL memory pool (Figure 1). There
also were qualitative differences in the CTL response, based on the data presented above in this report, that
intervening viral infections might sufficiently alter the Tas it would appear that as each virus was added, the
host decreased its reactivation of GP33-specific CTL, cell repertoire such that a secondary virus challenge
would elicit a considerably different T cell repertoirefavored reactivation of NP396-specific CTL, and main-
tained fairly consistent proportions of reactivated GP276- than that observed during the original acute infection.
For this experiment to be properly interpreted, wespecific CTL. This, with some exceptions, parallels the
selective alterations observed in the LCMV memory CD8 needed to examine windows in the T cell repertoire
where LCMV induced a distinct spectratype during thepool by LDA and intracellular IFNg staining, but it should
be noted that a secondary infection will cause a further acute infection, where the spectratype reverted to a
Gaussian distribution in the memory state, where in-selection of the T cell repertoire, and a secondary LCMV
infection of mice immune only to LCMV drives a selective tervening viral infections did not substantially alter this
Gaussian distribution, and where LCMV would reacti-proportional expansion of NP396-specific CTL and de-
cline of GP33-specific CTL. Note that LCMV1PV1VV- vate the original dominant clones. We would then ask
whether the intervening infections changed the reper-immune mice have proportionally high levels of GP33-
specific pCTL as shown by LDA. However, this does toire induced by LCMV.
Figure 7 shows that the conditions for proper interpre-not occur when the LCMV1PV1VV-immune mouse is
rechallenged in vivo with LCMV. Upon secondary chal- tation of this experiment were met by examining the
Vb8.1 CDR3 spectratypes emanating from Jb1.3 primerlenge, the host consistently uses the NP396-specific
repertoire preferentially. Therefore, there appears to be extension reactions of individual mice whose blood was
sequentially sampled as a source of T cells. Here, wea selection for the NP396-specific response, which hap-
pens to be the highest affinity response (Hudrisier et al., are examining LCMV-induced T cell responses rather
than responses clearly defined as LCMV specific, as it1996). The GP33 memory pool that is documented to
proportionally increase after PV and VV challenge in LDA was not feasible to purify LCMV peptide±specific T cells
from peripheral blood by Db-IgG1 MHC dimer sorting.may be of low affinity for LCMV and therefore not highly
reactivated by LCMV in vivo. The results from this experi- LCMV-immune mice received subsequent infections
with PV and VV and then a secondary 5 day acute infec-ment are consistent with the concept that heterologous
viral infections alter preexisting memory T cell pools and tion with LCMV. Control LCMV-immune mice were inoc-
ulated with culture fluid from the cells in which PV andshow that the secondary bulk CTL response to a virus
is quantitatively and qualitatively altered by intervening VV were grown and then challenged with LCMV. All of
the control mice showed a skewed response in the acuteviral infections.
infection, a Gaussian distribution in the memory state
after subsequent culture fluid injections and before sec-Modulations in the TcR Usage as Assessed
by Spectratype Analysis ondary LCMV challenge, and a pronounced dominant
peak on secondary challenge, thus fulfilling the condi-The acute LCMV infection in C57BL/6 mice induces
many dominant clones of T cells within the Vb8.1 popula- tions for an interpretable analysis (Figure 7). LCMV-
immune mice subsequently inoculated with PV and VVtion. Many of these clones can be revealed by CDR3
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all demonstrated Gaussian spectratypes prior to the sec- Welsh, 1998a); (S. M. V., L. K. S., and R. M. W., unpub-
lished data). Alternatively, there may be direct mecha-ondary LCMV challenge. After this challenge, however,
three out of four mice in each of the two experiments nisms that selectively eliminate memory cells in order
to make room for a newly responding population. Duringdemonstrated new spectratype peaks on secondary
LCMV infection. This is consistent with the concept that the acute response to LCMV infection, there is in fact an
attrition of T cells not specific to the virus. For example,these mice modulated their LCMV-induced TcR reper-
toire as some new memory T cell clones expanded and transgenic or else tolerized T cell populations known
to be non-cross-reactive with LCMV decline in numberother normally anticipated LCMV-induced T clones dis-
appeared. during a vigorous T cell response to LCMV (Zarozinski
and Welsh, 1997). These non-LCMV-specific T cells dis-
play enhanced reactivity with Annexin V, which detects
cells in the early stages of apoptosis (Welsh andDiscussion
McNally, 1999). Other cytokines or even virus infection
of lymphocytes might also contribute to the loss of mem-We have shown here that heterologous virus infections
can cause significant decreases in otherwise stable vi- ory T cells, but such nonspecific mechanisms are diffi-
cult to reconcile with selectivity.rus-specific CD8 T cell memory. This virus-induced de-
crease in T cell memory had previously been docu- In this study we show that there is not only a quantita-
tive reduction in CD8 T cell memory after heterologousmented using LDA against virus-infected targets (Selin
et al., 1996). In the present study, similar total decreases infections but also a qualitative alteration. The relative pro-
portions of memory T cells specific to each of the threewere observed by summation of LCMV epitope±specific
CD8 cells by LDAs, by flow cytometry for intracellular LCMV-encoded immunodominant peptides changed in
relationship to each other after heterologous infections,IFNg-producing cells, and by frequency analysis of CD8
T cells binding Db-IgG1 MHC dimers. Decreases in the and IFNg-producing cell assays suggested that the cells
most vigorously synthesizing IFNg may be selectivelysecondary bulk CTL response to LCMV-encoded pep-
tides were also shown to occur after several intervening lost. Additionally, we noted that a prior history of a virus
infection can influence the hierarchy of the T cell re-viral infections. It is noteworthy that the tetramer, Db-IgG1
MHC dimer, and the IFNg-producing cell assay tech- sponse to immunodominant peptides of a second unre-
lated virus on challenge. For example, the hierarchy ofniques are all excellent techniques to quantitate antigen-
specific cells, but they are all limited by their ability the memory pool laid down by an LCMV infection of
naive mice differed from that laid down by LCMV infec-to resolve a signal over background staining by FACS
analysis. The LDA is orders of magnitude more sensitive tion of PV- or VV-immune mice. These qualitative changes
in memory occurring as a consequence of prior or sub-than these procedures in that it can accurately detect
much lower frequencies of antigen-specific T cells. More sequent infections with heterologous viruses may well
reflect the proclivity of memory T cells to cross-reactthan 10% of the CD8 T cell pool in LCMV-immune mice
was shown to be LCMV-specific by the intracellular with other antigens. We have previously defined cross-
reactive memory T cell responses between heterolo-IFNg assay, as shown previously (Murali-Krishna et al.,
1998), and comparable numbers on LCMV-specific gous viruses, leading to the postulation that any deletion
in T cell memory would not affect all memory cellsmemory CD8 T cells were shown here for the first time
with Db-IgG1 MHC dimer staining. Given this high fre- equally.
Indeed, the results presented here are consistent withquency of antigen-specific memory cells, the reduction
in memory T cells on subsequent infection is not surpris- the concept that CD8 memory T cells cross-reactive
with the challenge virus are maintained while the non-ing, as the memory pool would fill to capacity very
quickly if the host were to maintain antigen-specific cross-reactive memory T cells are deleted. When LCMV
immune mice were acutely infected with VV, the LCMVmemory pools of this size for all the pathogens it would
encounter in a lifetime. In order to accommodate an in- GP33-specific CTL were preferentially reactivated. In
LCMV1PV1VV-immune mice there has been a greatercreasing memory pool in a limited shelf space, the sim-
plest method would be to delete some of the preexisting loss of NP396-specific pCTL and retention of GP33-
specific pCTL, suggesting that the potentially cross-memory cells as new infections occur.
reactive T cells were maintained. It would thus appearThis deletion of the preexisting memory pool may be
that the highly efficient immune system is able to main-a consequence of an antigen-specific expansion of CD8
tain homeostasis by saving space with two mechanisms,T cells in response to a subsequent infection, followed
either the deletion of a portion of the memory CD8 T cellby a competition for protective niches in the spleen and
pool or the preservation of cross-reactive CD8 memory Tlymphoid organs as the immune system downregulates
cells.at the end of infection. It is noteworthy that CD8 T cell
responses to PV and VV in LCMV-immune mice occur
more rapidly and limit spread of the virus, but they reach Experimental Procedures
substantial levels and subsequently impact the LCMV-
Virus Infection of Micespecific memory pool (Selin et al., 1994, 1996, 1998;
LCMV (strain Armstrong), VV (strain WR), PV (strain AN3739), andWelsh et al., 1997). The CD4 T cell pool does not increase
VSV (strain Indiana) were propagated in L929 or BHK21 cells (Welshin size as dramatically during these viral infections, ei-
et al., 1976; Yang et al., 1989). MCMV (strain Smith) was obtained
ther alone or during sequential infections, and there is from salivary glands of infected BALB/c mice (Bukowski et al., 1983).
less of a loss in the stable LCMV-specific CD4 memory Mutant strains of LCMV with partial deletions of their responses to
the NP epitope (NPV), GP33 epitope (GP1V), or all three (NP396,T cells after heterologous viral infections (Varga and
Selective Attrition of CD8 Memory T Cells
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GP33, GP276) immunodominant epitopes (GPNPV) were kindly do- Intracellular IFNg Staining
Splenocytes were stimulated with peptide (5 mg/ml) in the presencenated to us by Dr. M. B. A. Oldstone (Scripps Institute, San Diego,
CA) (Oldstone et al., 1995). C57BL/6 (H-2b) male mice were pur- of 10 U/ml human recombinant IL-2 and 10 mg/ml Brefeldin A (Sigma)
for 5 hr at 378C. The cells were stained with tricolor-conjugated anti-chased from The Jackson Laboratories and used at 2±26 months
of age. For acute virus infections, mice were injected i.p. with 4 3 mouse CD8 (clone CT-CD8, Caltag) and fixed with 2% paraformalde-
hyde as described previously (Varga and Welsh, 1998b). They were104 PFU of LCMV, 1±2 3 106 PFU of VV, 106±107 PFU of PV, 104 PFU
of MCMV, or 108 PFU of VSV. then permeabilized with 0.5% saponin before adding PE-conjugated
rat anti-mouse anti-IFNg mAb (PharMingen) or control PE-conju-
gated rat IgG1 isotype. They were analysyzed on either a FACS 440
Cell Lines (Becton Dickinson) or FACStar Plus (Becton Dickinson).
KO (H-2b), an SV40-transformed kidney cell line derived from a
C57BL/6 mouse (Tanaka and Tevethia, 1988) was propagated in Db-IgG1 MHC Dimer Staining
DMEM (GIBCO Laboratories) supplemented with 5 3 1025 M 2-ME. T cells were stained with a mouse IgG1-H-2Db fusion protein in
MC57G (H-2b), a fibroblast cell line from C57BL/6 mice was propa- which the antibody heavy chain was fused to the MHC class I a
gated in Eagle's MEM (GIBCO Laboratories). KO and MC57G cells chain such that MHC class I was expressed on the antigen-binding
were infected with LCMV at a multiplicity of infection (MOI) of 0.01± domain of the antibody molecule (Dal Porto et al., 1993; Greten et
0.02 PFU/cell and incubated for 2 days at 378C. The RMA-S cell line al., 1998). When these molecules are incubated with b2-microglobu-
(H-2b) is a T cell lymphoma that has been mutated, resulting in loss lin and the appropriate peptide, a complete peptide-loaded MHC
of the TAP2 gene (Attaya et al., 1992). These cells were propagated class I molecule is formed, and this can be used for the enumeration
in RPMI-1640 medium (Sigma Chemical) as described (Selin and of antigen-binding T cells. In our hands, this has shown similar
Welsh, 1997). percentages of LCMV-specific CD8 T cells as that reported with
MHC tetramers (Murali-Krishna et al., 1998). For these studies, the
Db-IgG1 MHC dimer (2 mM) was prepared as previously describedInfection Protocol with Heterologous Viruses
for other class I molecules (Dal Porto et al., 1993), incubated withAfter the rise and fall of the acute T cell response to one virus and
b2-microglobulin (4 mM) and appropriate peptide (80 mM) for 10when the immune system had returned to homeostasis (usually 6
days. For staining, 16 ml of the peptide-Db-IgG1 MHC dimer mixtureweeks or longer), the mouse was challenged with another virus.
was incubated on splenocytes for 3±4 hr at 48C. After washing, theThese viruses were used either in crude tissue culture supernatants
cells were incubated for 20 min with biotinylated anti-mouse IgG1or were purified over sucrose gradients and diluted in PBS. Control
(Pharmingen) at 48C. The cells were washed and then incubatednaive mice were either left uninoculated or else were inoculated
with streptavidin PE and CD8 FITC for 20 min at 48C. They werewith tissue culture media or with culture media sedimented like virus
then washed and fixed with 2% paraformaldehyde before analysisover a sucrose gradient. The control mice were always age matched
by FACS 440 or FACStar Plus.to the experimental group and housed under exactly the same
pathogen-free conditions as the experimental group for the identical
CDR3 Length Spectratypingtime period. All mice used were healthy with no evidence of any
The Vb8.1, Cb, and Jb primer sequences were used as previouslyunderlying disease.
described (Pannetier et al., 1993; Lin and Welsh, 1998). Vb8.1 and
Cb primers used for RT±PCR reactions were synthesized by BioSyn-
LDA for Peptide-Specific pCTL thesis. Fluorescent Jb primers were synthesized and labeled at the
Adult C57BL/6 mice were inoculated i.p. with the sequence of vi- 59 end with fluorophores by PE Applied Biosystems. Total RNA was
ruses indicated, and at the indicated times postinfection spleens extracted from peripheral blood by the acid-guanidinium thiocya-
were harvested. The LCMV epitope±specific p/CTL frequency per nate-phenol-chloroform method (Lin and Welsh, 1998). RNA sam-
CD81 T cell was quantified by LDAs of unsorted cells performed as ples, equivalent to 0.12 ml of blood, were amplified by using a
previously described (Selin et al., 1994). GeneAmp RNA PCR kit (Perkin-Elmer) with Vb8.1 and Cb primers,
according to the manufacturer's instructions.
Two microliters of the amplified PCR products were subjected to
Cytotoxicity Assays a cycle of run-off with radiolabeled Jb primers or five cycles of
Cell-mediated cytotoxicity was determined using a standard micro- run-off with fluorophore-labeled Jb primers. One microliter of the
cytotoxicity assay (Selin et al., 1994). Varying numbers of effector fluorescent products was mixed with an equal volume of gel-loading
leukocytes were plated in triplicate to achieve the desired E/T ratio. buffer and loaded onto a 4.75% acrylamide sequencing gel. The
51Cr-labeled MC57G target cells (5 3 103), either uninfected or in- results were analyzed on an automated DNA sequencer using Gene-
fected with virus, or RMA-S cells, either untreated or pulsed with Scan software (PE Applied Biosystems).
peptides, were added to all wells, and after a 6 hr incubation at 378C
the supernatant was harvested and counted. Data are expressed Statistical Analyses
as percent specific 51Cr-release 5 100 3 [(experimental cpm 2 The ANOVA test was used for data analysis where appropriate.
spontaneous cpm) / maximum release cpm 2 spontaneous release
cpm)]. Lytic units were calculated using the exponential fit method
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